Concepedia

Impact of American Academy of Pediatrics Palivizumab Guidance for Children ≥29 and <35 Weeks of Gestational Age

Tracy N. Zembles, Glenn Bushee, Rodney E. Willoughby

The Journal of Pediatrics · 2019 · 15 citations · 9 references

Concepts

PharmacyChild HealthPediatricsPediatric Clinical PharmacologyPediatric PharmacotherapyCare Of Premature InfantsIntrauterine Growth RestrictionClinical Gestational Age AssessmentGestational Age LimitsGestational Age MeasurementNeonatal Gestational Age Assessment

References

9

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

PEDIATRICS · 1998 · 1.9K citations

Pharmacy, Pediatrics, Pharmacotherapy +16

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Michael T. Brady, Carrie L. Byington, H. Dele Davies et al. · PEDIATRICS · 2014 · 774 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Respiratory syncytial virus infection

Eric A. F. Simões · The Lancet · 1999 · 614 citations

Life Sciences, Infectious Diseases, Microbiology +12

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Michael T. Brady, Carrie L. Byington, H. Dele Davies et al. · PEDIATRICS · 2014 · 390 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Respiratory syncytial virus infection

Eric A. F. Simões · The Lancet · 1999 · 110 citations

Life Sciences, Infectious Diseases, Microbiology +12